Home » Topics » Regulatory » Patents

Patents
RSS

GT32-B: a novel antibacterial/antitumor immunosuppresant

July 12, 1996

Sankyo reveals potential immunosupressants

July 12, 1996

Immunosuppressive and antiinflammatory agents from Italfarmaco

July 12, 1996

Antiinflammatory bone resorption inhibitors from Takeda

July 12, 1996

Bayer discloses matrix metalloproteinase inhibitors

July 12, 1996

COX-2 inhibitors for inflammation and/or pain from Roche

July 12, 1996

Novel antibacterial agents from Pharmacia & Upjohn

July 12, 1996

Erythromycin derivatives useful for infection treatment

July 12, 1996

Lilly describes heterocyclic tachykinin antagonists

July 12, 1996

Sandoz reports new NMDA antagonist

July 5, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 1, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
New evidence links autoimmunity to long COVID symptoms
BioWorld
Recent findings are reshaping current understanding of the post-infection landscape of SARS-CoV-2. Although previous studies had already suggested that...
Breakthrough as GSK’s bepirovirsen clears 19% of chronic hep B infections
BioWorld
GSK plc has announced a breakthrough in the treatment of chronic hepatitis B, reporting a functional cure rate of 19% across two phase III trials of its antisense...
BMS’ mezigdomide doubles PFS in multiple myeloma
BioWorld
Bristol Myers Squibb Co. disclosed in March 2026 that the phase III portion of the seamless phase II/III Successor-2 study testing mezigdomide in combination with...